Calpena AC

References (6)

Title : Zinc-Modified Mordenite Zeolite as a Molecular Carrier for Donepezil: A Framework for Drug Delivery Applications - Guaya_2025_Molecules_30_
Author(s) : Guaya D , Espinoza LC , Jaramillo-Fierro X , Gualotuna Campoverde D , Sosa L , Calpena AC
Ref : Molecules , 30 : , 2025
Abstract :
PubMedSearch : Guaya_2025_Molecules_30_
PubMedID: 41226137

Title : Zinc-Modified Mordenite Zeolite as a Molecular Carrier for Donepezil: A Framework for Drug Delivery Applications - Guaya_2025_Molecules_30_
Author(s) : Guaya D , Espinoza LC , Jaramillo-Fierro X , Gualotuna Campoverde D , Sosa L , Calpena AC
Ref : Molecules , 30 : , 2025
Abstract :
PubMedSearch : Guaya_2025_Molecules_30_
PubMedID: 41226137

Title : Zinc-Modified Mordenite Zeolite as a Molecular Carrier for Donepezil: A Framework for Drug Delivery Applications - Guaya_2025_Molecules_30_
Author(s) : Guaya D , Espinoza LC , Jaramillo-Fierro X , Gualotuna Campoverde D , Sosa L , Calpena AC
Ref : Molecules , 30 : , 2025
Abstract :
PubMedSearch : Guaya_2025_Molecules_30_
PubMedID: 41226137

Title : Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization - Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
Author(s) : Espinoza LC , Vacacela M , Clares B , Garcia ML , Fabrega MJ , Calpena AC
Ref : CNS Neurol Disord Drug Targets , 17 :43 , 2018
Abstract :
PubMedSearch : Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
PubMedID: 29299992

Title : Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization - Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
Author(s) : Espinoza LC , Vacacela M , Clares B , Garcia ML , Fabrega MJ , Calpena AC
Ref : CNS Neurol Disord Drug Targets , 17 :43 , 2018
Abstract :
PubMedSearch : Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
PubMedID: 29299992

Title : Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization - Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
Author(s) : Espinoza LC , Vacacela M , Clares B , Garcia ML , Fabrega MJ , Calpena AC
Ref : CNS Neurol Disord Drug Targets , 17 :43 , 2018
Abstract :
PubMedSearch : Espinoza_2018_CNS.Neurol.Disord.Drug.Targets_17_43
PubMedID: 29299992